Having trouble viewing this email? View it online here
Drug Discovery Today
Thermo Scientific
          WEBSITE           MAGAZINE REGISTRATION           EVENTS           CONTACTS                                                                     RSS   RSS feed

Drug Discovery Today News - 16 Apr 2012

Editor's Choice

In silico ADMET models: is the future really bright? In silico models, a phrase used to express ‘modelling performed on computer or via computer simulation’, is an area of very active development and has great potential across the pharmaceutical industry and also in other industries, such as the consumer goods and chemical industries, where ‘non-animal alternatives’ are being actively sought for assuring the safety of chemicals. More

RNAi & Nanotechnology

Key Research Articles

CRT unveils ‘screen test’ for potential drugs to treat oestrogen positive breast cancer Cancer Research UK and its commercial arm, Cancer Research Technology have developed a unique test to discover molecules that could lead to potential new treatments for oestrogen receptor (ER)-positive breast cancer. More

ELA 2012

Rainforest remedy could spell end of dental pain An ancient Incan toothache remedy – for centuries handed down among an indigenous people in the rainforests of Peru – could be on the cusp of revolutionising worldwide dental practice. More

Pharma Outsourcing & Procurement Summit 2012

Brain network provides hope for tinnitus sufferers As Brain Awareness Week (12–18 March) gets underway in the UK, the preliminary findings from the latest tinnitus research suggest that hearing aids might help tinnitus sufferers; research is ongoing into the role the brain has, and how tinnitus symptoms are reflected in brain network activity. More

13th International Conference on Alzheimers Drug Discovery

Scientists develop first ‘snap shot’ of tiny brain tumours Cancer Research UK scientists have developed a technique they believe could be used to detect tiny secondary tumours in the brain, a process that is currently impossible, according to research published in PNAS. More

Webinars for DDT

£10 million boost for neglected tropical disease research at Dundee The University of Dundee has received over £10 million from the Wellcome Trust in the fight against some of the world’s most neglected parasitic diseases, including support for a multi-million pound partnership with GlaxoSmithKline (GSK) to discover new drug treatments. More

Label-Free Technologies: Advances and Applications. (1-3 November 2012).

Downloads/ White Papers

The value of in silico chemistry in the safety assessment of chemicals in the consumer goods and pharmaceutical industries
28 March 2012
In this article Sandeep Modi, Michael Hughes, Andrew Garrow and Andrew White discuss limitations and strengths of in silico tools. Additionally, they look at different parameters that are necessary to make the best use of these tools, and also how to gain acceptance outside the modelling community and into the regulatory arena.
More

In silico repositioning of approved drugs for rare and neglected diseases
28 March 2012
Sean Ekins, Antony J. Williams, Matthew D. Krasowski and Joel S. Freundlich discuss how drug repurposing will emerge for neglected or rare and/or orphan diseases. Using proof-of-principle examples, they suggest that with current in silico technologies and databases of the structures and biological activities of chemical compounds (drugs) and related data, as well as close integration with in vitro screening data, improved opportunities for drug repurposing will emerge for neglected or rare/orphan diseases.
More

Toward in silico structure-based ADMET prediction in drug discovery
28 March 2012
In this article Gautier Moroy, Virginie Y. Martiny, Philippe Vayer, Bruno O. Villoutreix and Maria A. Miteva discuss recently reported in silico studies aiming at predicting small molecules binding to ADMET-related proteins based on the knowledge of the 3D structures of these macromolecules with a special emphasis on metabolizing enzymes.
More

Computational models for predicting substrates or inhibitors of P-glycoprotein
28 March 2012
Lei Chen, Youyong Li, Huidong Yu, Liling Zhang and Tingjun Hou review in silico approaches and computational models for identifying substrates or inhibitors of P-gp. The advances in the datasets for model building and available computational models are summarized and the advantages and drawbacks of these models are outlined.
More

For a full list of downloads/ white papers, please visit
http://www.drugdiscoverytoday.com/downloads/

Events

Companion Diagnostics: from Early Drug Discovery to Clinical Application
Dates: 01 May 2012 (1 day event)
Location: The Oxford Belfry, Oxford, UK
Website: http://www.elrig.org/index.php/events/123-companion-diagnost...
More

Cancer Centers of Excellence
Dates: 15 May 2012 until 17 May 2012
Location: 590 West Peachtree Street NW, Atlanta, GA 30308, USA
Website: http://www.gtcbio.com/index.php?option=com_conference&file=h...
More

30th Noordwijkerhout-Camerino-Cyprus Conference. Trends in Drug Research
Dates: 13 May 2012 until 17 May 2012
Location: Royal Tropical Institute, Amsterdam, The Netherlands
Website: http://www.noordwijkerhoutcc2012.com/
More

2nd Genomic & Proteomic Drug Discovery
Dates: 30 May 2012 until 31 May 2012
Location: Hyatt Harborside, Boston, MA, USA
Website: http://www.gtcbio.com/component/conference/?file=home&cn=2nd...
More

7th Protein Kinases in Drug Discovery Conference
Dates: 30 May 2012 until 31 May 2012
Location: Hyatt Harbor Hotel,Boston, MA, USA
Website: http://www.gtcbio.com/component/conference/?file=home&cn=7th...
More

For a full list of events and conferences, please visit
http://www.drugdiscoverytoday.com/events/

Received this from a colleague? Sign up for your own regular copy of Drug Discovery Today Weekly.

This e-mail has been sent to you from Elsevier, The Boulevard, Langford Lane, Kidlington, Oxford OX5 1GB, registered in England with registered number 1982084.

You are receiving this e-mail because you are a registered subscriber of Drug Discovery Today. We respect your privacy and do not rent, sell or disclose your personal information to any non-affiliated third party without your consent, except as may be stated in our site's Privacy Policy: http://www.drugdiscoverytoday.com/legal/privacy/